{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:32:35Z","timestamp":1793968355657,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015511","name":"Wockhardt Bio AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.diagmicrobio.2021.115327","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T18:23:15Z","timestamp":1612030995000},"page":"115327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["In vitro activity of cefepime\/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5943-5031","authenticated-orcid":false,"given":"Sachin S.","family":"Bhagwat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Legakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilemachos","family":"Skalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-7366","authenticated-orcid":false,"given":"Anastassios","family":"Loannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Goumenopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant R.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal R.","family":"Palwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Periasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-8355","authenticated-orcid":false,"given":"Stylianos","family":"Chatzipanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0001","series-title":"Advisory committee briefing materials: Available for public release","author":"Shionogi","year":"2021"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0002","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. M-07-A11","year":"2018"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01931-18","article-title":"In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model","volume":"63","author":"Almarzoky Abuhussain","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0004","series-title":"Surveillance of antimicrobial resistance in Europe 2017","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0005","series-title":"Surveillance of antimicrobial resistance in Europe 2018","year":"2019"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115327_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00948-18","article-title":"Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model","volume":"62","author":"Avery","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2021.115327_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.105863","article-title":"Evaluation of the in vitro activity of WCK 5222 (cefepime\/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope","volume":"55","author":"Avery","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2021.115327_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02146-18","article-title":"The novel beta-lactam enhancer zidebactam augments the in vivo pharmacodynamic activity of cefepime in a neutropenic mouse lung Acinetobacter baumannii infection model","volume":"63","author":"Bhagwat","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0009","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/jac\/dkx049","article-title":"Hellenic Cefiderocol Study G. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals","volume":"72","author":"Falagas","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"31","key":"10.1016\/j.diagmicrobio.2021.115327_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","article-title":"Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016","volume":"23","author":"Galani","year":"2018","journal-title":"Euro Surveill"},{"issue":"suppl_2","key":"10.1016\/j.diagmicrobio.2021.115327_bib0011","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China","volume":"67","author":"Hu","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2021.115327_bib0012","article-title":"Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: a nationwide study from 2014 to 2017","volume":"55","author":"IMouna","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2021.115327_bib0013","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/AAC.00285-06","article-title":"High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35\/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe","volume":"50","author":"Kaczmarek","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2021.115327_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01432-20","article-title":"In vitro activity of WCK 5222 (cefepime-zidebactam) against worldwide collected gram-negative bacilli not susceptible to carbapenems","volume":"64","author":"Karlowsky","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2021.115327_bib0015","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/jac\/dkz294","article-title":"Activity of cefepime\/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres","volume":"74","author":"Khan","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0016","first-page":"149","article-title":"Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model","volume":"75","author":"Kidd","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhin.2010.03.021","article-title":"Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin","volume":"76","author":"Kontopoulou","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0018","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2021.115327_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01648-19","article-title":"WCK 5222 (cefepime\/zidebactam) pharmacodynamic target analysis against metallo-beta-lactamase producing enterobacteriaceae in the neutropenic mouse pneumonia model","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl_1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0020","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2021.115327_bib0021","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3201\/eid2404.171377","article-title":"Phenotypic and genotypic characterization of enterobacteriaceae producing oxacillinase-48-like carbapenemases, United States","volume":"24","author":"Lutgring","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115327_bib0022","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/JCM.40.11.4388-4390.2002","article-title":"Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa","volume":"40","author":"Migliavacca","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2021.115327_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00233-19","article-title":"In vivo efficacy of wck 5222 (cefepime-zidebactam) against multidrug-resistant Pseudomonas aeruginosa in the neutropenic murine thigh infection model","volume":"63","author":"Monogue","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115327_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01022-17","article-title":"Efficacy of humanized exposures of cefiderocol (S-649266) against a diverse population of gram-negative bacteria in a murine thigh infection model","volume":"61","author":"Monogue","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115327_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01238-17","article-title":"Potent beta-lactam enhancer activity of zidebactam and WCK 5153 against Acinetobacter baumannii, including carbapenemase-producing clinical isolates","volume":"61","author":"Moya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02529-16","article-title":"WCK 5107 (Zidebactam) and WCK 5153 are novel inhibitors of PBP2 showing potent \"beta-lactam enhancer\" activity against Pseudomonas aeruginosa, including multidrug-resistant metallo-beta-lactamase-producing high-risk clones","volume":"61","author":"Moya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2021.115327_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00128-19","article-title":"In vitro and in vivo activities of beta-lactams in combination with the novel beta-lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-beta-lactamase-producing Klebsiella pneumoniae","volume":"63","author":"Moya","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0028","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/jac\/dkaa036","article-title":"Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa","volume":"75","author":"Moya","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2021.115327_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01669-19","article-title":"Comparative Evaluation of the In Vitro Activities of WCK 5222 (Cefepime-Zidebactam) and Combination Antibiotic Therapies against Carbapenem-Resistant Pseudomonas aeruginosa","volume":"64","author":"Mullane","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0030","series-title":"Population pharmacokinetics, Monte Carlo simulations and dosing recommendations of cefepime using 90 minutes infusion, including renal impairment, EP0943","author":"Muller","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0031","series-title":"Population pharmacokinetics of zidebactam (WCK 5107), a novel beta-lactam enhancer antibiotic, in individuals with various renal functions, P1954","author":"Muller","year":"2019"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2021.115327_bib0032","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.fis2019.po0008","article-title":"In-vitro activity of cefiderocol against multidrug-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii isolates from the UK","volume":"2","author":"Mushtaq","year":"2020","journal-title":"Access Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2021.115327_bib0033","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"Supplement_7","key":"10.1016\/j.diagmicrobio.2021.115327_bib0034","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00102-19","article-title":"The global ascendency of OXA-48-type carbapenemases","volume":"33","author":"Pitout","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0036","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ijantimicag.2017.01.028","article-title":"Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study","volume":"49","author":"Pournaras","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2021.115327_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00072-17","article-title":"WCK 5222 (Cefepime-Zidebactam) antimicrobial activity against clinical isolates of gram-negative bacteria collected worldwide in 2015","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0038","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/jac\/dkx050","article-title":"WCK 5222 (cefepime\/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant beta-lactamases","volume":"72","author":"Sader","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2021.115327_bib0039","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","article-title":"Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY Antimicrobial Surveillance Program, 1997-2016","volume":"6","author":"Shortridge","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2021.115327_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115327_bib0041","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/jac\/dkn364","article-title":"First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests","volume":"62","author":"Tsakris","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0042","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijid.2014.05.021","article-title":"Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia","volume":"28","author":"Uz Zaman","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115327_bib0043","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. Available http:\/\/www.eucast.org."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:55:27Z","timestamp":1760003727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0732889321000201"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115327","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of cefepime\/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115327"}}